(223)Matsugana Yoichi ., Wakatsuki Yoshio ., Tabata Yasuhiko., Kawasaki Hideo., Usui Takashi ., Yoshida Masaru ., Itoh Toshiyuki., Habu Sonoko., Kita Yoru .
Oral immunization with size-purified microsphere beads as a vehicle selectively indcues systemic tolerance and sensitization.
Vaccine, 19, 579-588 (2001)
(224)Yamamoto M., Ikada Y., Tabata Y.
Controlled release of growth factors based on biodegradation of gelatin hydrogel
J Biomater Sci Polym Ed, 12, 77-88, (2001)
(225)佐藤 江利子, 笠原 啓史, 篠崎 芳郎, スベルラート ボルチヒーナ, 田中 越郎, 田畑 泰彦, 折井 正博, 小出 司郎策, 盛 英三
生体吸収性徐放化ゲルによる遺伝子導入効率の改善
呼吸と循環 49, 285-290, (2001)
(226)田畑 泰彦
再生医学における材料学の役割、再生医学と組織工学ー現状と今後の課題
医学のあゆみ, 第１土曜特集号、196, 301-306 (2001)
(227)田畑 泰彦
再生医学ってなんだ 心筋の再生
Mebio, 18, 110-115, (2001)
(228)Kawaguchi H., Nakamura K., Tabata Y., Ikada Y., Aoyama I., Anzai J., Nakamura T., Hiyama Y., Tamura M.
Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2
J Clin Endocrinol Metab, 86, 875-80, (2001)
(229)Tabata Y.
Recent progress in tissue engineering
Drug Discov Today, 6, 483-487, (2001)
(230)田畑 泰彦
関西電力株式会社発行 縁
99, 20-20, (2001)
(231)田畑 泰彦.
再生医学における生体材料の重要性、
先端ウオッチィング調査「21世紀の化学の潮流を探る」 No.6「バイオマテリアル: 生命機能の制御と再生医療をめざして」, 29-41, (2001)
(232)田畑 泰彦
基礎医学から呼吸器へのメッセージ、ＤＤＳの最前線
分子呼吸病学, 5, 63-64, (2001)
(233)Suginoshita Y., Tabata Y., Moriyasu F., Ikada Y., Chiba T.
Liver targeting of interferon-beta with a liver-affinity polysaccharide based on metal coordination in mice
J Pharmacol Exp Ther, 298, 805-11, (2001)
(234)田畑 泰彦
特集「再生医学」に見る２１世紀医療の可能性
Doctor’s Magazine, ５月号, 7-15, (2001)
(235)田畑 泰彦
ティッシュエンジニアリングと再生医学
Doctor’s Magazine ８月号, 38-39 (2001)
(236)中野 貴由, 海原 一裕, 馬越 佑吉, 田畑 泰彦, 長田 奈津紀, 洪 流, 榎本 昭二, 丸川 恵理子
再生医学と材料工学との融合、Hap結晶の配向性を利用した生体硬組織の評価
Boundary, 17, 10-13, (2001)
(237)田畑 泰彦
細胞成長因子の放出制御と血管新生
組織培養工学, 27, 8-11, (2001)
(238)John A., Hong L., Ikada Y., Tabata Y.
A trial to prepare biodegradable collagen-hydroxyapatite composites for bone repair
J Biomater Sci Polym Ed, 12, 689-705, (2001)
(239)Gu Y., Tabata Y., Kawakami Y., Balamurugan A. N., Hori H., Nagata N., Satake A., Cui W., Qi M., Misawa Y., Toma M., Miyamoto M., Nozawa M., Inoue K.
Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation
Cell Transplant, 10, 453-7, (2001)
(240)Nagata N., Gu Y., Hori H., Balamurugan A. N., Touma M., Kawakami Y., Wang W., Baba T. T., Satake A., Nozawa M., Tabata Y., Inoue K.
Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix
Cell Transplant, 10, 447-51, (2001)
(241)田畑 泰彦
組織工学研究の最新の動向、特集：再生医療の最前線と産業化への取り組み
Bioベンチャー, 1, 44-51, (2001)
(242)田畑 泰彦
細胞増殖因子の徐放化技術を用いた骨再建
THE BONE, 15, 45-48, (2001)
(243)Wang J., Tabata Y., Bi D. Z., Morimoto K.
Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres
Journal of Controlled Release, 73, 223-231, (2001)
(244)Mligiliche N., Tabata Y., Endoh K., Ide C.
Peripheral nerve regeneration through a long detergent-denatured muscle autografts in rabbits
Neuroreport, 12, 1719-22, (2001)
(245)Nakase H., Okazaki K., Tabata Y., Uose S., Ohana M., Uchida K., Nishi T., Debreceni A., Itoh T., Kawanami C., Iwano M., Ikada Y., Chiba T.
An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis
J Pharmacol Exp Ther, 297, 1122-8, (2001)
(246)田畑 泰彦
細胞増殖因子と生体再生
遺伝子医学, 5, 111-114 (2001)
(247)仲瀬 裕志, 千葉 勉, 田畑 泰彦
Drug delivery systemを応用した炎症性腸疾患治療法の開発
医学のあゆみ, 199, 119-123, (2001)
(248)Iwakura A., Tabata Y., Koyama T., Doi K., Kataoka K., Nohara R., Fujita M., Nishimura K.
Gelatin sheet incorporating basic fibroblast growth factor enhances heating of the devascularized sternum in a large animal model.
Circulation, 104, 404-404, (2001)
(249)Kawai K., Suzuki S., Tabata Y., Taira T., Ikada Y., Nishimura Y.
Development of an artificial dermis preparation capable of silver sulfadiazine release
J Biomed Mater Res, 57, 346-56, (2001)
(250)Yasukawa T., Kimura H., Tabata Y., Ogura Y.
Biodegradable scleral plugs for vitreoretinal drug delivery
Adv Drug Deliv Rev, 52, 25-36, (2001)
(251)Kimura H., Yasukawa T., Tabata Y., Ogura Y.
Drug targeting to choroidal neovascularization
Adv Drug Deliv Rev, 52, 79-91, (2001)
(252)Hosseinkhani H., Aoyama T., Ogawa O., Tabata Y.
In vitro transfection of plasmid DNA by different-cationized gelatin with or without ultrasound irradiation
Proceedings of the Japan Academy Series B-Physical and Biological Sciences, 77, 161-166, (2001)
(253)Tabata Y., Ikada Y.
Significance of drug delivery in tissue engineering.
Tissue Engineering and Biodegradable Equevalents: Scientific and Clinical Applications, D.L. Wise Ed., Marcel Dekker, Inc, New York, 145-163, (2001)
(254)Hong L., Miyamoto S., Yamada K., Hashimoto N., Tabata Y.
Enhanced formation of fibrosis in a rabbit aneurysm by gelatin hydrogel incorporating basic fibroblast growth factor
Neurosurgery, 49, 954-60; discussion 960-1, (2001)
(255)Mori H., Kasahara H., Sato E., Hattan N., Tanaka E., Ando K., Shinozaki Y, Kuwabara E., Kimura K., Fukuyama N., Iseki H., Ban K., Ssakamoto H., Tabata Y.
Salvaging ischemic myocardium by tissue engineering.
Tissue Engineering for Therapeutic Use5. Y.Ikada and N.Oshima, Eds., 113-116, (2001)
(256)Kamizuru H., Kimura H., Yasukawa T., Tabata Y., Honda Y., Ogura Y.
Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat
Invest Ophthalmol Vis Sci, 42, 2664-72, (2001)
(257)Nakase H., Okazaki K., Tabata Y., Uchida K., Uose S., Ohana M., Nishi T., Watanabe T., Matsuura M., Hisatsune H., Matsumura K., Itoh T., Kawanami C., Chiba T.
Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination
Vaccine, 20, 377-84, (2001)
(258)Morimoto K., Katsumata H., Yabuta T., Iwanaga K., Kakemi M., Tabata Y., Ikada Y.
Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin
Eur J Pharm Sci, 13, 179-85, (2001)
(259)田畑 泰彦
組織再生とその臨床への応用
DDS, 16, 465-473, (2001)
(260)Ueda H., Nakamura H., Tabata Y., Shimizu Y.
Repairing of rabbit skull defect by TGF-b1-incorporated collagen sponges of different thickness.
Proceedings of the 5th Asian Symposium on Bimedical Materials (ASBM5), Jack CY Cheng and Y Leng Eds., Hong Kong, 193-197, (2001)
(261)Yeung HY ., Law LP., Lee KM. , Cheng JCY , Chow P, Tabata Y.
The effect of vascular endothelial growth factor combined with hydrogel in a posterior spinal fusion model.
Proceedings of the 5th Asian Symposium on Bimedical Materials (ASBM5), Jack CY Cheng and Y Leng Eds., Hong Kong, 292-297, (2001)
(262)Hossein H., Aoyama T., Ogawa O., Tabata Y.
Targeting of plasmid DNA to the liver through pullulan conjugation based on metal coordination.
Proceedings of the 5th Asian Symposium on Bimedical Materials (ASBM5), Jack CY Cheng and Y Leng Eds., Hong Kong, 323-328, (2001)
(263)Yeung HY., Cheng WH. , Law LP ., Cheng JCY ., Lee KM., Tabata Y.
Culture of rabbit chondrocytes released from rib cage on calcium ceramics and collagen sponge.
Proceedings of the 5th Asian Symposium on Bimedical Materials (ASBM5), Jack CY Cheng and Y Leng Eds., Hong Kong, 338-342, (2001)
(264)Yamamoto M., Sakakibara Y., Nishimura K., Komeda M, Tabata Y.
Improved efficacy in cardiomyocyte transplantation for myocardial infarction therapy through prevascularization induced by controlled release of basic fibroblast growth factor.
Proceedings of the 5th Asian Symposium on Bimedical Materials (ASBM5), Jack CY Cheng and Y Leng Eds., Hong Kong, 469-474, (2001)
(265)Ozeki M., Tabata Y.
Controlled release of hepatocyte growth factor from gelatin hydrogels.
Proceedings of the 5th Asian Symposium on Bimedical Materials (ASBM5), Jack CY Cheng and Y Leng Eds., Hong Kong, 483-443, (2001)
(266)Kimura Y., Inamoto T., Tabata Y.
Adipose tissue engineering by preadipocytes combined with controlled releaseof basic fibroblast growth factor.
Proceedings of the 5th Asian Symposium on Bimedical Materials (ASBM5), Jack CY Cheng and Y Leng Eds., Hong Kong, 519-524, (2001)
(267)Tabata Y.
Significance of biomaterials and drug delivery systems in tissue engineering,
Connective Tissue, 33, 315-324, (2001)
(268)Ozeki M., Ishii T., Hirano Y., Tabata Y.
Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation
J Drug Target, 9, 461-71, (2001)
(269)Nakano T. , Kaibara K., Umakoshi Y., Tabata Y.
Texture of hydroxyapatite (HAp) crystralline in typical biologicakl hard tissues
Proceedings of the Fourth Pancific Rim International Conference on Advanced Materails and Processing (PRICM 4), S. Harada, Z.Zhong, S.W, Nam, and R.N. Wright, Eds., The Japan Institute of Metals, , 225-228, (2001)
(270)田畑 泰彦
再生医科学における生体材料の役割と重要性
関西TLO技術情報クラブ会報, 3, 1-2, (2001)
(271)Tabata Y.
Role of Biomaterials and Drug Delivery Systems in Tissue Engineering,
Nigata Symposium of Nephrology 2001, A New Aspects in Regeneration and Replacement Medicine for Kideney Diseases. A, M. Arakawa, Ed, 31-59, (2001)
(272)Saito A., Junichin J, Kazama., Iino N, Cho Kenji., Sato N., Yamazaki H., Oyama Y., Orlando. Robert A., Shimizu F., Tabata Y., Gejyo F.
Bioengineered subcutaneous implantation of megalin-expressing cells facilitates beta2-microglobulin metabolism in renal failure.
Nigata Symposium of Nephrology 2001, A New Aspects in Regeneration and Replacement Medicine for Kideney Diseases. A, M. Arakawa, Ed, 121-124, (2001)
(273)Ogawa K., Asonuma K., Inomata Y., Kim I., Ikada Y., Tabata Y., Tanaka K.
The efficacy of prevascularization by basic FGF for hepatocyte transplantation using polymer devices in rats
Cell Transplant, 10, 723-9, (2001)
|